Lucy Scientific Discovery (LSDI) Stock Analysis

What Lucy Scientific Discovery does

Lucy Scientific Discovery Inc. focuses on the entire lifecycle of psychedelic products, from their initial research and development to their production and subsequent market release. The company's offerings include fundamental biological raw materials, unprocessed extracts, a variety of psychotropic compounds, and critical active pharmaceutical ingredients (APIs). Established in 2017, this firm, formerly known as Hollyweed North Cannabis, Inc., is headquartered in Victoria, Canada.

Key metrics

ETFs linked to LSDI

Broad-market and Healthcare sector ETFs an investor holding Lucy Scientific Discovery is often also exposed to. Open an ETF page to see its actual top holdings.

PortView Portfolio Insights

PortView analyzes how LSDI fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Similar companies

Frequently asked questions

What is the ticker symbol for Lucy Scientific Discovery?

Lucy Scientific Discovery trades under the ticker LSDI on NASDAQ.

Which exchange is LSDI listed on?

LSDI is listed on NASDAQ.

What sector does Lucy Scientific Discovery operate in?

Lucy Scientific Discovery is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

How can PortView help analyze LSDI in a portfolio?

PortView shows LSDI's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.